Viewing Study NCT02495103


Ignite Creation Date: 2025-12-24 @ 7:46 PM
Ignite Modification Date: 2026-01-03 @ 1:14 AM
Study NCT ID: NCT02495103
Status: TERMINATED
Last Update Posted: 2021-01-26
First Post: 2015-07-08
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma
Sponsor: National Cancer Institute (NCI)
Organization: